# Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma

> **NCT00893490** · PHASE1 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences**

## Conditions studied

- Refractory Glaucoma

## Interventions

- **DEVICE:** Ahmed Glaucoma Valve (AGV)
- **DRUG:** Mitomycin C (MMC)
- **PROCEDURE:** amniotic membrane coverage

## Key facts

- **NCT ID:** NCT00893490
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00893490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00893490, "Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00893490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*